Becker’s Healthcare: Halting 340B funding would force 73% of hospitals to cut staff, study finds

If the 340B Drug Pricing Program were restricted or no longer available, safety-net hospitals would face a myriad of challenges, according to a recent study by 340B Health. Signed into ...

The Hill: When drug prices threaten patient care

The debate over high drug prices has raged for decades, thanks to the inherent tension between delivering innovative and cost-effective patient care. But recently something has changed, and it’s one ...

Value Walk: How To Boost Drug Companies’ Profits Without Hurting Poor Americans

A Free Market Reform that Can Help Everybody Drug companies, like all for-profit companies, are all about profits. Their basic job is to take investors’ money and use it to ...

Modern Healthcare: Commentary: Guidance on 340B drug program delivers mismatch of policy, priorities from HHS

The Obama administration and HHS Secretary Sylvia Mathews Burwell have admirable goals for our nation’s healthcare system: greater provider collaboration; prevention and keeping people well after a hospital visit; payments ...

Drug Discount Monitor: Protect 340B, Cardiologist Asks Congress at Hearing on Drug Prices

The chief clinical officer of one of Indiana’s largest safety-net hospitals implored Congress to protect the 340B drug discount program in light of “hyperinflation in pharmaceutical pricing.” “I understand that ...

Want To Stay Up-To-Date On The Latest 340B News?

"*" indicates required fields